- $2.32bn
- $3.70bn
- $3.08bn
- 96
- 66
- 98
- 99
2019 June 30th | 2020 June 30th | R2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,751 | 2,481 | 2,576 | 2,888 | 3,080 |
Cost of Revenue | |||||
Gross Profit | 1,350 | 1,232 | 1,276 | 1,395 | 1,439 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,587 | 2,425 | 2,501 | 2,840 | 3,016 |
Operating Profit | 164 | 56 | 75.2 | 47.3 | 64.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 127 | 3 | -63.6 | 9.33 | -30.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 93.5 | -29.5 | -82.5 | -50.6 | -186 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 95.1 | 83.4 | -85.2 | -54.3 | -186 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 95.1 | 83.4 | -85.2 | -54.3 | -186 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.89 | 1.64 | -1 | -1.96 | -5.86 |